CME Group Inc.
CMENASDAQ
USReal-Time Price
USReal-Time Price$293.53USD
-0.34 (-0.12%)Today
$294.23+0.70 (+0.24%)After Hours7:59 PM ET
BTI Score
Near Future
67
Long Term
71
BTI Fair Market Cap
$51.50B
+104.97% vs fair
Financials
High Risk
CME Group Inc. (CME) Stock Analysis
BTI's proprietary analysis of CME Group Inc. (CME): overall score, long- and short-term outlook, risk rating and fair-value verdict based on fundamentals, valuation and momentum.
Major-Firm Consensus
Buy
Filtered to 21 major global investment banks
Buy
11
Hold
7
Sell
3
Price Target Consensus
High
$337.00
Consensus
$292.94
Low
$218.00
Current
$293.53
Upside: -0.2%
Target Trend
Last Month— (0)
Last Quarter— (0)
Last Year— (0)
Ratings History — Major Investment Banks
| Firm | Rating | Action | Previous | Price Target | Upside | Date |
|---|---|---|---|---|---|---|
| Bank of America Securities | Sell | Maintains | — | — | — | Oct 15, 2026 |
| Goldman Sachs | Sell | Maintains | — | $254.00 | -13.5% | Oct 14, 2026 |
| Wells Fargo | Buy | Reiterates | — | — | — | Oct 14, 2026 |
| Morgan Stanley | Buy | Maintains | — | — | — | Oct 9, 2026 |
| TD Cowen | Buy | Maintains | — | — | — | Oct 5, 2026 |
| UBS | Hold | Maintains | — | — | — | Oct 5, 2026 |
| Barclays | Hold | Maintains | — | $270.00 | -8.0% | Oct 5, 2026 |
| Piper Sandler | Buy | Maintains | — | $295.00 | +0.5% | Oct 2, 2026 |
Annual Analyst Estimates
| Fiscal Year | Revenue Avg | Revenue Range | EPS Avg | EPS Range | Analysts |
|---|---|---|---|---|---|
| FY 2026 | $7.05B | — – — | $12.31 | — – — | — |
| FY 2027 | $7.37B | — – — | $13.00 | — – — | — |
Want deeper AI-powered analysis?
Get BTI AI's full investment thesis, valuation models, and risk assessment for CME.